Using data from more than 330,000 doctors and 12 pharmaceutical firms, it identified 58% as having received payments. It found that payments were unlikely to represent significant opportunities to educate doctors about new drugs, and that financial gain appears to be an important motive for doctors.
Daniel Carlat, director of the prescription project at the non-profit group Pew Trusts, says research to date shows that doctors who have dealings with drugs reps "tend to prescribe differently".
"They prescribe more drugs, more expensive drugs, more brand-name drugs, and they're less likely to follow evidence-based practice guidelines in prescribing drugs.
Group items matching
in title, tags, annotations or url
1More
1More
Why Doctors Hate Their Computers | The New Yorker - 0 views
The Moral Dilemmas of Doctors During Disaster : The New Yorker - 0 views
1More
Should Patients Be Allowed to Choose - or Refuse - Doctors by Race or Gender? - The New... - 0 views
5More
My Great-Great-Aunt Discovered Francium. And It Killed Her. - NYTimes.com - 0 views
4More
How Measurement Fails Doctors and Teachers - The New York Times - 1 views
1More
Doctors in Denmark want to stop circumcision for under-18s | The Independent - 1 views
3More